Yvonne Wirth

Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer??s Disease

Anders Wimo, Bengt Winblad, Albrecht Stöffler et al. · PharmacoEconomics · 2003 · 167 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +16

Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy

Alireza Atri, José Luís Molinuevo, Ole Lemming et al. · Alzheimer s Research & Therapy · 2013 · 124 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus

M. Suckfüll, Michael Althaus, Barbara Ellers‐Lenz et al. · BMC Ear Nose and Throat Disorders · 2011 · 63 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD

Rainer Hellweg, Yvonne Wirth, Wolfgang Janetzky et al. · International Journal of Geriatric Psychiatry · 2011 · 54 citations

Medicine, Pharmacology, Pharmacotherapy +16

Specific Functional Effects of Memantine Treatment in Patients with Moderate to Severe Alzheimer’s Disease

Rachelle S. Doody, Yvonne Wirth, Frederick A. Schmitt et al. · Dementia and Geriatric Cognitive Disorders · 2004 · 52 citations

Medicine, Pharmacology, Pharmacotherapy +17